Applikationsformen der spezifischen immuntherapie

Translated title of the contribution: Administration schedules of specific immunotherapy

Matthias V. Kopp*, Andrea Heinzmann

*Corresponding author for this work
5 Citations (Scopus)

Abstract

Allergen-specific immunotherapy is, along with allergen avoidance, the only specific treatment for allergic disorders. Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the two main forms of administration. Other possible forms of local administration, such as nasal, oral or bronchial immunotherapy, have not yet been proven safe and/or efficacious. There are different preparations for both SCIT and SLIT. In the case of SCIT, aqueous, depot and semidepot preparations are available. With respect to SLIT, there are drops and tablets, the latter, however, up to now only for patients with grass pollen allergy. Current knowledge suggests that success of specific immunotherapy depends on the cumulative dose of allergen administered. This article will present the different administration schedules of immunotherapy, differences in terms of efficacy and safety will not be addressed.

Translated title of the contributionAdministration schedules of specific immunotherapy
Original languageGerman
JournalAllergo Journal
Volume16
Issue number8
Pages (from-to)570-575
Number of pages6
ISSN0941-8849
DOIs
Publication statusPublished - 12.2007

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Administration schedules of specific immunotherapy'. Together they form a unique fingerprint.

Cite this